Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

More Blind, Placebo Trials Of Anticoagulant Drugs Urged

More Blind, Placebo Trials Of Anticoagulant Drugs Urged Drugs are very good—if you don't use them," Michael Schwartz, MD, of Glastrup Hospital in Copenhagen, told The Journal. He reported to The International Symposium on Anticoagulants in Ischemie Heart Disease, the results of a four-year controlled study of anticoagulant therapy which was conducted in two Copenhagen hospitals. Although data indicated that there was not a definite reduction in the mortality of acute myocardial infarction following anticoagulant treatment, there was evidence that thromboembolic complications were significantly reduced in the group treated with anticoagulants. "But this same effect—the reduction of thromboembolic complications—can be achieved in the patient by early mobilization. Why should one recommend treatment that might be dangerous, when it is possible to follow nature's way?" Schwartz asked. "It is a curious but well established fact that discussion of anticoagulant treatment in acute myocardial infarction very often brings up severe emotions," he added. "It would be my http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

More Blind, Placebo Trials Of Anticoagulant Drugs Urged

JAMA , Volume 187 (7) – Feb 15, 1964
Download PDF
1 page

More Blind, Placebo Trials Of Anticoagulant Drugs Urged

Abstract


Drugs are very good—if you don't use them," Michael Schwartz, MD, of Glastrup Hospital in Copenhagen, told The Journal.
He reported to The International Symposium on Anticoagulants in Ischemie Heart Disease, the results of a four-year controlled study of anticoagulant therapy which was conducted in two Copenhagen hospitals. Although data indicated that there was not a definite reduction in the mortality of acute myocardial infarction following anticoagulant...
Loading next page...
 
/lp/american-medical-association/more-blind-placebo-trials-of-anticoagulant-drugs-urged-j4CN0iKTO2

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright © 1964 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1964.03060200093047
Publisher site
See Article on Publisher Site

Abstract

Drugs are very good—if you don't use them," Michael Schwartz, MD, of Glastrup Hospital in Copenhagen, told The Journal. He reported to The International Symposium on Anticoagulants in Ischemie Heart Disease, the results of a four-year controlled study of anticoagulant therapy which was conducted in two Copenhagen hospitals. Although data indicated that there was not a definite reduction in the mortality of acute myocardial infarction following anticoagulant treatment, there was evidence that thromboembolic complications were significantly reduced in the group treated with anticoagulants. "But this same effect—the reduction of thromboembolic complications—can be achieved in the patient by early mobilization. Why should one recommend treatment that might be dangerous, when it is possible to follow nature's way?" Schwartz asked. "It is a curious but well established fact that discussion of anticoagulant treatment in acute myocardial infarction very often brings up severe emotions," he added. "It would be my

Journal

JAMA – American Medical Association

Published: Feb 15, 1964

There are no references for this article.